Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

3.87
Delayed Data
As of Aug 18
 -0.02 / -0.51%
Today’s Change
2.35
Today|||52-Week Range
4.84
+40.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues4.5M30.0M20.9M25.3M
 
 
 
 
 
Cost of Goods Sold936.0K10.0M6.6M6.3M
 
 
 
 
 
Depreciation And Amortization649.0K2.2M2.2M3.0M
 
 
 
 
 
 
Operating ExpensesGross Income2.9M17.9M12.1M16.0M
 
 
 
 
 
General Expenses16.9M34.5M34.2M30.5M
 
 
 
 
 
Research And Development476.0K637.0K3.2M0.00
 
 
 
 
Total Operating Expenses18.5M46.6M43.0M39.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.0M-16.6M-22.1M-14.6M
 
 
 
 
 
Extraordinary Credit20.8M0.000.000.00
 
 
Extraordinary Charge-2.7M0.000.00-1.4M
 
 
 
Interest Expense On Debt87.0K1.5M2.3M2.5M
 
 
 
 
 
Other Expenses825.0K-110.0K-132.0K-971.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.9M-18.2M-24.5M-19.5M
 
 
 
 
 
Income Taxes-102.0K-49.0K-11.0K-152.0K
 
 
 
 
 
Net Income4.8M-18.2M-24.5M-19.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.8M16.2M18.2M25.3M
 
 
 
 
 
Shares To Calculate EPS Diluted12.9M16.2M18.2M25.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.37-$1.12-$1.34-$0.78
 
 
 
 
 
EPS Diluted$0.37-$1.12-$1.34-$0.79